Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-045598
Filing Date
2023-02-23
Accepted
2023-02-23 06:58:38
Documents
5
Effectiveness Date
2023-02-23

Document Format Files

Seq Description Document Type Size
1 S-8 d469019ds8.htm S-8 37617
2 EX-5.1 d469019dex51.htm EX-5.1 6210
3 EX-23.1 d469019dex231.htm EX-23.1 1950
4 EX-FILING FEES d469019dexfilingfees.htm EX-FILING FEES 17063
5 GRAPHIC g469019g0221120802319.jpg GRAPHIC 2533
  Complete submission text file 0001193125-23-045598.txt   67571
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-269925 | Film No.: 23655855
SIC: 2836 Biological Products, (No Diagnostic Substances)